We are live on ! Find out more
US Bancorp

US Bancorp Portfolio holdings

AUM $82.4B
1-Year Est. Return 19.69%
This Fund
S&P 500
This Quarter Est. Return
-5.06%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$48.4B
AUM Growth
-$3.14B
Cap. Flow
-$231M
Cap. Flow %
-0.48%
Top 10 Hldgs %
30.2%
Holding
4,340
New
176
Increased
1,269
Reduced
1,824
Closed
174

Sector Composition

Rank Sector Weight
1 Technology 11.43%
2 Healthcare 8.99%
3 Financials 7.75%
4 Industrials 6.06%
5 Consumer Staples 5.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAFE
2376
DELISTED
Safehold Inc.
SAFE
$68K ﹤0.01%
2,561
-5,466
-68% -$213K
ABCB icon
2377
Ameris Bancorp
ABCB
$5.85B
$67K ﹤0.01%
1,506
-2,114
-58% -$96.9K
EMBJ
2378
Embraer S.A. ADS
EMBJ
$12.2B
$67K ﹤0.01%
7,832
+1,462
+23% +$14.5K
IMCV icon
2379
iShares Morningstar Mid-Cap Value ETF
IMCV
$1.14B
$67K ﹤0.01%
1,200
-300
-20% -$18.6K
JAMF
2380
DELISTED
Jamf
JAMF
$67K ﹤0.01%
3,045
+1,129
+59% +$27.9K
LIVN icon
2381
LivaNova
LIVN
$4.4B
$67K ﹤0.01%
1,322
-112
-8% -$6.65K
PINC
2382
DELISTED
Premier
PINC
$67K ﹤0.01%
1,971
-473
-19% -$17.2K
ROCK icon
2383
Gibraltar Industries
ROCK
$1.25B
$67K ﹤0.01%
1,617
-380
-19% -$16.2K
CVSA
2384
Covista Inc
CVSA
$4.25B
$66K ﹤0.01%
1,834
+35
+2% +$1.34K
OPTU
2385
Optimum Communications Inc
OPTU
$298M
$66K ﹤0.01%
11,459
-389
-3% -$3.73K
AUPH icon
2386
Aurinia Pharmaceuticals
AUPH
$1.91B
$66K ﹤0.01%
8,820
EVT icon
2387
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
$2.1B
$66K ﹤0.01%
3,053
MASS icon
2388
908 Devices
MASS
$329M
$66K ﹤0.01%
+4,018
New +$78K
NVMI
2389
Nova
NVMI
$12.4B
$66K ﹤0.01%
771
+42
+6% +$4.13K
SRNE
2390
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$66K ﹤0.01%
41,880
+4,846
+13% +$11K
MYGN icon
2391
Myriad Genetics
MYGN
$270M
$65K ﹤0.01%
3,422
-186
-5% -$4.27K
OM icon
2392
Outset Medical
OM
$84.7M
$65K ﹤0.01%
271
+98
+57% +$26.2K
RWL icon
2393
Invesco S&P 500 Revenue ETF
RWL
$9.62B
$65K ﹤0.01%
978
+378
+63% +$27.8K
SPB icon
2394
Spectrum Brands
SPB
$2.04B
$65K ﹤0.01%
1,672
+269
+19% +$17.3K
URNM icon
2395
Sprott Uranium Miners ETF
URNM
$1.76B
$65K ﹤0.01%
2,000
TBRG
2396
DELISTED
TruBridge
TBRG
$65K ﹤0.01%
2,318
+2,247
+3,165% +$69.3K
ARNC
2397
DELISTED
Arconic Corporation
ARNC
$65K ﹤0.01%
3,769
-256
-6% -$6.64K
EBF icon
2398
Ennis
EBF
$552M
$64K ﹤0.01%
3,163
+656
+26% +$13.8K
GAB icon
2399
Gabelli Equity Trust
GAB
$1.75B
$64K ﹤0.01%
11,616
-1,042
-8% -$6.42K
LKFT
2400
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.78B
$64K ﹤0.01%
1,496
-154
-9% -$7.89K

Similar funds

US Bancorp's Q3 2022 Portfolio in Review

As of Q3 2022, US Bancorp held 4,340 positions worth $48.4B, down 6.1% from $51.6B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

US Bancorp's Q3 2022 filing shows 176 new, 1,269 increased, 1,824 reduced and 174 closed positions. Its largest new stake was Goldman Sachs Access Treasury 0-1 Year ETF: 30,834 shares worth $3.08M. The largest sale was Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF, an estimated $271M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Healthcare and Financials.

  • US Bancorp's largest Q3 2022 buy was Goldman Sachs Access Treasury 0-1 Year ETF: 30,834 shares worth $3.08M.
  • US Bancorp added most to Vanguard FTSE Developed Markets ETF in Q3 2022, an estimated $241M increase.
  • US Bancorp's biggest Q3 2022 reduction was Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF, cutting an estimated $271M.
  • US Bancorp fully exited PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES) in Q3 2022, selling an estimated $9.57M.
  • US Bancorp's ten largest holdings make up 30% of its $48.4B portfolio in Q3 2022.
  • US Bancorp opened 176 new positions and closed 174 in Q3 2022.
  • US Bancorp's portfolio value fell 6.1% quarter-over-quarter to $48.4B.

Based on US Bancorp's 13F filing for Q3 2022, filed 27 Oct 2022.